The paired analysis of selenoprotein P concentrations in both CSF and serum showed some positive association in controls and in subjects with MCI and ALS but not in patients with AD, possibly due to metabolic reasons or alterations of the blood–brain barrier. This evidence concerns the gene SELENOP and amyotrophic lateral sclerosis.